Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sinocelltech Group Ltd

688520
Current price
32.13 CNY -0.94 CNY (-2.84%)
Last closed 32.6 CNY
ISIN CNE100003ZL3
Sector Healthcare
Industry Biotechnology
Exchange Shanghai Stock Exchange
Capitalization 14 295 568 635 CNY
Yield for 12 month -38.09 %
1Y
3Y
5Y
10Y
15Y
688520
21.11.2021 - 28.11.2021

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and vaccines in China. The company offers AnpingxiA (repertuzumab injection), an anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of solid tumors; SCT-I10A, a monoclonal antibody injection which is in phase 3 trials for the treatment of solid tumors; SCTV01, a new generation vaccine which is in phase 3 trials for the treatment of corona virus; SCT510 for the treatment of solid tumors; SCT200, a monoclonal antibody injection for the treatment of solid tumors; and SCT1000, which is in phase 3 clinical trials for the treatment of human papillomavirus, as well as SCTA01 which is in phase 2/3 clinical research trials for the treatment of SARS COV-2. The company was founded in 2007 and is based in Beijing, China. Sinocelltech Group Limited operates as a subsidiary of Lhasa Alike Investment Consulting Co., Ltd. Address: No. 31 Kechuang 7th Street, Beijing, China, 100176

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

486.58 CNY

P/E ratio

Dividend Yield

Current Year

+1 876 280 903 CNY

Last Year

+1 017 176 232 CNY

Current Quarter

+688 107 047 CNY

Last Quarter

+608 911 319 CNY

Current Year

+1 822 059 274 CNY

Last Year

+983 498 388 CNY

Current Quarter

+664 177 976 CNY

Last Quarter

+588 545 305 CNY

Key Figures 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 488 629 296 CNY
Operating Margin TTM 30.87 %
PE Ratio
Return On Assets TTM 8.14 %
PEG Ratio
Return On Equity TTM -3864.41 %
Wall Street Target Price 486.58 CNY
Revenue TTM 2 369 962 985 CNY
Book Value -1.02 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 44.4 %
Dividend Yield
Gross Profit TTM 1 017 176 256 CNY
Earnings per share -0.3 CNY
Diluted Eps TTM -0.3 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 223.6 %
Profit Margin -5.56 %

Dividend Analytics 688520

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.1003
Price Sales TTM 6.032
Enterprise Value EBITDA 137.4162
Price Book MRQ

Financials 688520

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688520

For 52 weeks

31.01 CNY 56.17 CNY
50 Day MA 36.08 CNY
Shares Short Prior Month
200 Day MA 42.89 CNY
Short Ratio
Shares Short
Short Percent